Figure 3.

Annual weight gain (kg/year) by pre-switch PI- or NNRTI-based regimens to specific INSTI agents (A). Annual weight gain (kg/year) by the post-switch combination of INSTI and NRTI (B). Abbreviations: ABC, abacavir; CI, confidence interval; DTG, dolutegravir; EVG, elvitegravir; INSTI, integrase strand transfer inhibitor; NNRTI, nonnucleoside reverse transcriptase inhibitor; NRTI, nucleoside reverse transcriptase inhibitor; PI, protease inhibitor; RAL, raltegravir; TAF, tenofovir alafenamide; TDF, tenofovir disoproxil fumarate.